Geron Corp. buy Slaandjivaa
Start price
16.01.18
/
50%
€1.94
Target price
01.03.18
€2.26
Performance (%)
8.12%
End price
01.03.18
€2.10
Summary
This prediction ended on 01.03.18 with a price of €2.10. The BUY prediction by Slaandjivaa finished with a performance of 8.12%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Geron Corp. | 8.992% | 8.992% | -27.139% | -35.010% |
| iShares Core DAX® | 0,02 % | 0,58 % | 11,67 % | 61,62 % |
| iShares Nasdaq 100 | 1,74 % | -2,06 % | 4,18 % | 88,71 % |
| iShares Nikkei 225® | 0,43 % | 10,49 % | 29,99 % | 67,05 % |
| iShares S&P 500 | 1,33 % | 0,14 % | 3,33 % | 60,86 % |
Comments by Slaandjivaa for this prediction
In the thread Geron Corp. diskutieren
Gerne Geron
https://seekingalpha.com/article/4137225-toxicity-gerons-imetelstat-may-lead-accelerated-fda-approval